Author:
Chakraborty Dwaipayan,Pati Subhadip,Bose Sayantan,Dhar Subhanki,Dutta Saikat,Sa Gaurisankar
Funder
Department of Science and Technology, Ministry of Science and Technology
Council of Scientific and Industrial Research
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Genetics,Molecular Biology,Molecular Medicine
Reference108 articles.
1. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008;14:5220–7.
2. Antonia SJ, Gettinger SN, Chow LQM, Juergens RA, Borghaei H, Shen Y. Nivolumab (anti-PD-1; BMS-936558, ONO-4538) and ipilimumab in first-lineNSCLC: interim phase I results. J Clin Oncol. 2014;32:74–86.
3. Au KM, Tripathy A, Lin CP. Bespoke pre targeted nanoradioimmunotherapy for the treatment of non-hodgkin lymphoma. ACS Nano. 2018;83:48–59.
4. Bates SE, Berry DA, Balasubramaniam S, Bailey S, LoRusso PM, Rubin EH. Advancing clinical trials to streamline drug development. Clin Cancer Res. 2015;21(20):4527–35.
5. Beier U, et al. Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival. FASEB J. 2015;29:2315–26.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献